Hepatitis B and pregnancy;Hépatite virale B et grossesse

Tunisie Medicale

Volumn 88, Issue 6, 2010, Pages 383-389

  Arfaoui, Dalenda ^a   Fkih, Meriem ^b   Eddine Hafsa, Alaa ^b   Kaabia, Naoufel ^b   Azzouz, Msadek ^c  

^a SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c Nabeul Hospital   (Tunisia)

Author keywords

Delivery; Hepatitis B; Pregnancy; Vertical transmission

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE;

DELIVERY; HEPATITIS B; HUMAN; MEDLINE; NONHUMAN; PASSIVE IMMUNIZATION; PERINATAL PERIOD; PREGNANCY; PREGNANT WOMAN; REVIEW; TUNISIA; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

FEMALE; FETAL DISEASES; HEPATITIS B; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 77954724488     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Organisation Mondiale de la Santé. Hépatite B. Fact sheet No 204. Revised August 2008
2. Hurie MB, Mast EE, Davis JP. Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees. Pediatrics 1992; 89: 269-73.3.
3. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-452.
4. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998 ; 27 : 100-6. (Pubitemid 28334427)
5. Denis F, Tabaste JL, Ranger-Rogez S. Prévalence de l'Ag HBs chez près de 21500 femmes enceintes. Enquête douze CHU français. Pathol Biol 1994 ; 42 : 533-8.
6. Denis F, Ranger-Rogez S, Alain S, et al. Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital(Limoges) during 15 years. Eur J Epidemiol 2004; 19: 973-8.
7. Marinler E, Barrols V, Larouze B. Transmission materno-f?tale du virus Ç de l'hépatite en Côte d'Ivoire. Cahiers Santé, 1998; 8: 401-4.
8. 8-Kuri U, Turan O, Kuru N, et al . Prevalence of hepatitis B virus infection in pregnant Turkish women and their families. Eur J Clin Microbiol Infect Dis 1996; 15 :248-51
9. Panagopoulos P, Economou A, Kassi,I A et al. Prevalence of hepatitis B and C in the maternity department in a Greek district hospital. J Matern Fetal Neonatal Med 2004; 16 :106-10
10. Elefsiniotis IS, Glynou I, Magaziotou I. HBe Ag negative serological status and low viral replication levels characterize chronic hepatitis B virus-infected women at reproductive age in Greece: A one-year prospective single center study. World J Gastroenterol 2005; 11:4879-82.
11. Coursaget P, Gharbi Y, Khrouf N ,et al. Familial clustering of hepatitis B virus infections and prevention of perinatal transmission by immunization with a reduced number of doses in an area of intermediate endemicity( Tunisia). Vaccine 1994; 12 : 257-8
12. Soltani MS,Bechir A, Slimane MN, Mtiraoui A, Ghannem H. Mother-child transmission of hepatitis B virus in the Tunisian Sahel.Rev Epidemiol Santé Publique 1994; 42 : 529-32
13. Hannachi N, bahri O,Mhalla S, et al. Hépatite B chez les femmes enceintes tunisiennes : facteurs de risque et intérêt de l'étude de réplication virale en cas d'antigène HBe négatif. PatholBiol 2008 ;4 :2649-53
14. Ranger-Rogez S, Alain S, Denis F. Virus des hépatites : transmission mère-enfant. Pathol Biol 2002;50:568-75.
15. Rawal BK, Paridas S, Watkins RP, Ghosh P, Smith H. Symptomatic reactivation of hepatitis B in pregnancy. Lancet 1991; 337: 364.
16. Soderstrom A, Norkrans G, Lindth. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003; 35: 814-9. (Pubitemid 38028916)
17. Xu DZ, Yan YP, Choi BC et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67: 20-6.
18. Zhang SL, Han XB and Yue YF. Relationship between HBV viremia level of pregnant women and intrauterine infection: nested PCR for detection of HBV DNA. WJG 1998 4: 61-3
19. Ghendon Y. Perinatal transmission of hepatitis B virus in high-incidence countries. J Virol Methods 1987; 17: 69-79. (Pubitemid 17136410)
20. Tse K Y, Ho L F, Lao T. The impact of maternal HBs Ag carrier status on pregnancy outcomes: Acase-control study. Journal of Hepatology 2005;43: 771-775. (Pubitemid 41414501)
21. Lee AK, Ip HM, Wong VC. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis 1978; 138: 668-71.
22. Schweitzer IL. Vertical transmission of the hepatitis B surface antigen. Am J Med Sci 1975; 270: 287-91.
23. Towers CV, Asrat, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J. Obstet Gynecol 2001 184 : 1514-18.
24. Alexander JM, Ramus R, Jackson G, Sercely B, Wendel GD. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol 1999; 7: 283-6.
25. Wang J. Zhu Q. Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J. 2002;115: 1510-12. (Pubitemid 35282912)
26. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus - a systematic review . Yang J, Zeng X, Men Y, Zhao L . J Virol. 2008; 5: 100.
27. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002 99 : 1049-52.
28. World Health Organization. Hepatitis B and breast feeding. J Int Assoc Physicians AIDS Care 1998; 4:20-1.
29. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20:992-1000.
30. McMahon BJ, Alberts SR, Wainwright RB et al. Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990; 150: 1051-4.
31. Ranger-Rogez S, Denis F. Hepatitis B mother-to-child transmission. Expert Rev Anti-infective Ther 2004;2 : 133-45.
32. Zuckermann JN. Hepatitis B immune globulin for prevention of hepatitis B infection. J Med Virol 2007; 79: 919-21.
33. Lee C, Gong Y, Brok J, Boxall EH, Gluud C Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006 ; 332: 328-36.
34. Del Canho R, Grosheide PM , Mazel JA. Ten-year neonatal hepatitis B vaccination program. The Netherlands, 1982-1992 : protective efficacy and long-term immunogenicity. Vaccine 1997 15 : 1624-30..
35. Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates.JViral Hepat 1999 6 : 135-9.
36. Velu V, Nandakumar S, Shanmugam S, et al . Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India .World J Gastroenterol 2007 ; 13 : 3084-9.
37. Mele A, Tancredi F, Romano L et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184 : 905-8.
38. Huang K, Lin S. Nationwide vaccination: a success story in Taïwan. Vaccine 2000; 18 (Suppl. 1): S35-8.
39. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997 336: 1855-9. 32.
40. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Eng J Med 1997; 336: 196-204.
41. Roome A, Rak M, Hadler J. Follow-up of infants of hepatitis B-infected women after hepatitis B vaccination, Connecticut, 1994 to 1997. Pediatr Infect Dis J 2000 ; 19 : 573-5. 11.
42. Soulie JC, Uzan M. L'allaitement accroît-il le risque de transmission de l'état de porteur chronique du virus de l'hépatite B ? Gastroenterol Clin Biol. 1997 ; 21: 197-9.
43. Huang LM, Chiang BL, Lee CY, et al. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B. Hepatology 1999; 29: 954-9.
44. Keeffe EB, Dieterich DT, Han SH, et al. A treatement algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol hepatol 2006; 4: 936-62.
45. EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatology 2009; 50: 227-242
46. Terrault NA, Jacobson IM. Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy. Emin Liver Dis 2007; 27(suppl 1) : 18-24.
47. Xu WM, Cui YT, Wang L,Yang H, Liang Z Q,Li XM.Efficacy and safety of lamivudine in late pregnancy for the prevention of mother-child transmission of hepatitis B; a multicentre, randomised, double blind placebo controled study. Hepatology 2004; 40(suppl 1):272 A
48. Su GG, Pan KH, Whao NF, Fang SH, Yang DH, Whou Y. Efficacy and safety of lamivudine treatement for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10: 910-2
49. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 2002 ; 359 : 1488-9.
50. Van Zonneved M ,Van Nunen AB,Niesters HG et al. Lamivudine treatement during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepatol 2003 ; 10 : 294-7.
51. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16 :94-103.
52. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BP, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission : a clinical study. World J. Gastroenterol. 2003 9 : 1501-3.
53. Li X, Shi M F, Yang Y B, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004;10 :3215-3217. (Pubitemid 39419894)
54. Xu Q, Xiao L, Lu X B, Zhang Y X, Cai X. A randomized controlled clinical trial: Interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006 ; 12 : 3434-7. (Pubitemid 43933793)
55. Leruez M, Dulioust E, Galimand J, Guibert J , Jouannet P, Rouzioux C. Virus et sperme : implications pour l'assistance médicale à la procréation Immuno-analyse & Biologie spécialisée 2006 ; 21:181-8.
56. Huang JM, Huang TH, Qiu HY, Fang XW, Zhuang TG, Liu HX, et al. Effects of hepatitis B virus infection on human sperm chromosomes. World J Gastroenterol 2003;9:736-40.
57. Honeck P, Weigel M, Kwon S T, Alken P,Bross S. Assisted procreation in cases of hepatitis B, hepatitis C or human immunodeficiency virus infection of the male partner. Human Reproduction 2006; 21 : 1117-21.